Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Bemis Company acquires rigid packaging operations of Emplal Participações S.A.

Bemis Company, Inc. today announced that it has acquired the rigid plastic packaging operations of Emplal Participações S.A.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Bemis Company, Inc. today announced that it has acquired the rigid plastic packaging operations of Emplal Participações S.A. ("Emplal"). Emplal, a privately-owned Brazilian manufacturer of plastic packaging for food and consumer applications, recorded annual net sales of R$225 million in 2014, or approximately US$58 million at today's exchange rate. Financial terms of the transaction were not disclosed. This transaction will not impact earnings per share guidance for 2015.

"This acquisition supports our growth strategy to expand in markets that fit our strengths and capabilities," said William F. Austen, President and Chief Executive Officer of Bemis Company, Inc. "We look forward to integrating these two facilities, which complement our manufacturing capabilities in the region, into our business during 2016. We expect this acquisition to be modestly accretive to earnings per share in 2016."

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?